Login
Navigate Fool.com
Will PDLI beat
the market?

PDL BioPharma

NASDAQ: PDLI

Community Rating: 3 Stars: Appealing

8.41 0.16 (1.94%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.25
Previous Close $8.25
Daily Range $8.11 - $8.48
52-Week Range $7.33 - $10.21
Market Cap $1.3B
P/E Ratio 5.07
Dividend (Yield) $0.60 (7.1%)
Ex-Dividend Date
Dividend Pay Date
06/03/14
06/12/14
Volume 4,166,992
Average Daily Volume 3,771,978
Current FY EPS $2.06

How do you think PDLI
will perform against the market?

Top PDLI Bull/Bear Pitches

 

TMFDeej (< 20)
Submitted August 29, 2010

PDL BioPharma (PDLI) is another interesting biotech wind-down. The company's revenue is derived mainly from seven patents that it was awarded between 1996 and 2000. During that period, the Dr. Cary … More

4 Replies Reply Report this Post
 

tutaemeia (< 20)
Submitted December 20, 2008

No way this guys will have good times soon. The fundamentals talk by themselves:<br /><br />Who will by a company with a P/B of 16x, have a ROE in the last 5y of -11, a P/S of 3,63x? Maybe you are loo … More

1 Replies Reply Report this Post

News & Commentary Rss Feed

5 Reasons to Buy PDL BioPharma Inc

PDL BioPharma will extend its operations beyond 2014. I believe there are 5 reasons the stock is now a buy.

Bullish Two Hundred Day Moving Average Cross - PDLI

Depomed A 'Turtle' Gaining In Specialty Pharma Race

PDLI Makes Notable Cross Below Critical Moving Average

Morning Movers in Biotech: Actavis plc, DepoMed, Inc. and Horizon Pharma, Inc.

Today's top stories in healthcare and biotech.

PDL BioPharma's Q4 Profit Jumps 24% on Higher Royalty Revenue

PDL BioPharma's royalty revenue and expenses vault higher, but its cash from operations grew solidly.

Earnings Reaction History: PDL BioPharma Inc, 100.0% Follow-Through Indicator, 9.8% Sensitive

PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 03, 2014

Ex-Dividend Reminder: PDL BioPharma, Commerce Bancshares and First Trust MLP and Energy Income Fund

PDLI Dividend Yield Pushes Above 7%

See More PDLI News...

Sector

Healthcare

Industry

Drugs

PDL BioPharma (PDLI) Description

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses. Website: http://www.pdl.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks